[Management of COVID-19: the Zhejiang experience]

The current epidemic situation of coronavirus disease 2019 (COVID-19) still remained severe. As the National Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Zhejiang University School of Medicine is the primary medical care center for COVID-19 in Zhejiang province. Based on the present expert consensus carried out by National Health Commission and National Administration of Traditional Chinese Medicine, our team summarized and established an effective treatment strategy centered on “Four-Anti and Two-Balance” for clinical practice.

The “Four-Anti and Two-Balance” strategy included antivirus, anti-shock, anti-hyoxemia, anti-secondary infection, and maintaining of water, electrolyte and acid base balance and microecological balance. Meanwhile, integrated multidisciplinary personalized treatment was recommended to improve therapeutic effect. The importance of early viralogical detection, dynamic monitoring of inflammatory indexes and chest radiograph was emphasized in clinical decision-making.

Sputum was observed with the highest positive rate of RT-PCR results. Viral nucleic acids could be detected in 10%patients’ blood samples at acute period and 50%of patients had positive RT-PCR results in their feces. We also isolated alive viral strains from feces, indicating potential infectiousness of feces.Dynamic cytokine detection was necessary to timely identifying cytokine storms and application of artificial liver blood purification system.

FcRn Antibody

DF12607-100ul 100ul
EUR 168
Description: WB,IHC

FcRn Antibody

DF12607-200ul 200ul
EUR 210
Description: WB,IHC

FcRn, His-Tag

71285-1 100 µg
EUR 345
Description: Human FcRn, also known as Neonatal Fc receptor, GenBank Accession number NM_001136019, a.a. 212-1313 with C-terminalHis-Tag. MW = 32 kDa, expressed in an HEK293 expression system.

FcRn, His-Tag

71285-2 1 mg
EUR 2940
Description: Human FcRn, also known as Neonatal Fc receptor, GenBank Accession number NM_001136019, a.a. 212-1313 with C-terminalHis-Tag. MW = 32 kDa, expressed in an HEK293 expression system.

FcRn Blocking Peptide

MBS9621312-1mg 1mg
EUR 380

FcRn Blocking Peptide

MBS9621312-5x1mg 5x1mg
EUR 1650

FcRn-Specific Antibody

abx233063-100g 100 µg
EUR 350

FcRn-Specific Antibody

abx233063-100ug 100 ug
EUR 661.2

FcRn-Specific antibody

E39-03063 100ug/100ul
EUR 225
Description: Available in various conjugation types.

FcRn-Specific Antibody

MBS9611359-01mL 0.1mL
EUR 260

FcRn-Specific Antibody

MBS9611359-02mL 0.2mL
EUR 305

FcRn-Specific Antibody

MBS9611359-5x02mL 5x0.2mL
EUR 1220

human FcRn, His tag

E410A15-10 10μg
EUR 495

human FcRn,His tag

E4A10L01 50ug
EUR 255
Description: Available in various conjugation types.

Human FcRn, His tag

MBS8575042-001mg 0.01mg
EUR 575

Human FcRn, His tag

MBS8575042-5x001mg 5x0.01mg
EUR 2440

Mouse FcRn ELISA Kit

MBS8248436-5x96Tests 5x96Tests
EUR 2880

Mouse FcRn ELISA Kit

MBS8248436-96Tests 96Tests
EUR 645

FCGRT/FCRN Rabbit mAb

A23161 100μL
EUR 1657.89
Description: A synthetic peptide corresponding to a sequence within amino acids 700-800 of human VAV3 (Q9UKW4).

FcRn (FCGRT/B2M) Blocker

101468-1 50 µg
EUR 355
Description: The FcRn (FCGRT/B2M) blocker (Fc-Tag) is a purified human protein corresponding to the Fc region of an antibody which has been engineered to bind to human neonatal Fc Receptor for IgG (FcRn; FCGRT/B2M) with high affinity. This antibody has been tested for specific binding to human FcRn (BPS Bioscience #71283) and it blocks the binding of FcRn with immunoglobulins G.

FcRn (FCGRT/B2M) Blocker

101468-2 100 µg
EUR 510
Description: The FcRn (FCGRT/B2M) blocker (Fc-Tag) is a purified human protein corresponding to the Fc region of an antibody which has been engineered to bind to human neonatal Fc Receptor for IgG (FcRn; FCGRT/B2M) with high affinity. This antibody has been tested for specific binding to human FcRn (BPS Bioscience #71283) and it blocks the binding of FcRn with immunoglobulins G.

FCGRT/FcRn (IgG Transporter)

MBS4380899-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

FCGRT/FcRn (IgG Transporter)

MBS4380899-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

FCGRT/FcRn (IgG Transporter)

MBS4380899-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

FCGRT/FcRn (IgG Transporter)

MBS4380899-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

FCGRT/FcRn (IgG Transporter)

MBS4380899-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

anti- FcRn-Specific antibody

FNab03063 100µg
EUR 702
Description: Antibody raised against FcRn-Specific

Recombinant Human FcRn Protein

RP01037 5 μg
EUR 297.57

Recombinant Mouse FcRn Protein

RP02030 500μg
EUR 258.6

FcRn-Specific Blocking Peptide

DF12607-BP 1mg
EUR 234

Recombinant Cynomolgus FcRn Protein

RP02363 500μg
EUR 258.6

Mouse FCRN/FCGRT ELISA Kit

EK5682 96 tests
EUR 599

Anti-FCGRT/FCRN Rabbit pAb

GB112081 100 μL
EUR 100

Rabbit Anti-Human FcRn/b2M Protein (FCGRT/FcRn 1-297aa+B2M 1-119aa heterodimer) IgG, Aff pure

FCRN11-A 100 ug
EUR 416.4

FCGRT/FCRN Recombinant Rabbit mAb

BS49115 50 ul
EUR 398
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt.

Sheep Polyclonal anti-mouse FCRN

mAP-5164 50ug
EUR 400

Human FcRn (FCGRT & B2M), His Tag

E24PHA115 50 μg
EUR 262

FcRn & B2M Heterodimer Recombinant Protein

92-311 0.05 mg
EUR 651.3
Description: FcRn complex consist of two subunits: IgG receptor FcRn large subunit p51(alpha chain) and Beta-2-microglobulin(Beta chain). The complexes is similar in structure to MHC class I-like heterodimer. Beta-2-microglobulin involved in the presentation of peptide antigens to the immune system. FcRn binds to the Fc region of monomeric immunoglobulins gamma, mediates the uptake of IgG from milk,Possible role in transfer of immunoglobulin G from mother to fetus. A principal component of antibody transport is the neonatal receptor for the Fc portion of immunoglobulin, a heterodimer of a MHC-1 alpha-chain homolog ( FcRn ) and beta-2-microglobulin ( B2M ).

FcRn & B2M Heterodimer Recombinant Protein

92-590 0.05 mg
EUR 481.2
Description: FcRn complex consist of two subunits: IgG receptor FcRn large subunit p51(alpha chain) and Beta-2-microglobulin(Beta chain). The complexes is similar in structure to MHC class I-like heterodimer. Beta-2-microglobulin involved in the presentation of peptide antigens to the immune system. FcRn binds to the Fc region of monomeric immunoglobulins gamma, mediates the uptake of IgG from milk,Possible role in transfer of immunoglobulin G from mother to fetus. A principal component of antibody transport is the neonatal receptor for the Fc portion of immunoglobulin, a heterodimer of a MHC-1 alpha-chain homolog ( FcRn ) and beta-2-microglobulin ( B2M ).

Human FcRn&b2M HEK293 Cell Line

E24C00187 each
EUR 1225
Description: Human

Recombinant Human FcRn Heterodimer Protein

RP02365 100μg
EUR 283.4

Human IgG receptor FcRn Rabbit mAb

E2R50150 100ul
EUR 385
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

IgG receptor FcRn large subunit p51

AP83191 1mg
EUR 2640

IgG receptor FcRn large subunit p51

AP83431 1mg
EUR 2640

Mouse FCRN/FCGRT PicoKine ELISA Kit

MBS178527-5x96StripWells 5x96-Strip-Wells
EUR 3935

Mouse FCRN/FCGRT PicoKine ELISA Kit

MBS178527-96StripWells 96-Strip-Wells
EUR 855

IgG receptor FcRn large subunit p51

MBS7042739-002mg 0.02mg
EUR 1660

IgG receptor FcRn large subunit p51

MBS7042739-01mg 0.1mg
EUR 2615

IgG receptor FcRn large subunit p51

MBS7042739-5x01mg 5x0.1mg
EUR 11730

Biotinylated Recombinant Cynomolgus FcRn Protein

RP02364 500μg
EUR 421.56

Anti-Human FCGRT/FCRN Antibody (SAA0135)

MBS1564415-01mg 0.1mg
EUR 405

Anti-Human FCGRT/FCRN Antibody (SAA0135)

MBS1564415-5x01mg 5x0.1mg
EUR 1520

Anti-Human FCGRT/FCRN Antibody (SAA0136)

MBS1564416-01mg 0.1mg
EUR 405

Anti-Human FCGRT/FCRN Antibody (SAA0136)

MBS1564416-5x01mg 5x0.1mg
EUR 1520

FCGRT/FCRN (16A10) Rabbit Monoclonal Antibody

E28M2155 100ul
EUR 295

Mouse FCRN/FCGRT ELISA Kit PicoKine®

EK1454 96 wells
EUR 750
Description: Mouse FCRN/FCGRT ELISA Kit PicoKine® (96 Tests). Quantitate Mouse Fcgrt in cell culture supernatants, serum, plasma (heparin, EDTA) and cell lysates. Sensitivity: 10pg/ml.

Recombinant (HEK) Human FcRn/b2M Protein (FCGRT/FcRn 1-297aa+B2M 1-119aa heterodimer protein, >95%, his-tag, ~44 kda, low endotoxins)

FCRN15-R-25 25 ug
EUR 416.4

Recombinant (HEK) Mouse FcRn/b2M Protein (FCGRT/FcRn 1-297aa+B2M 1-119aa heterodimer protein, >95%, his-tag, ~44 kda, low endotoxins)

FCRN16-R-25 25 ug
EUR 416.4

Mouse Neonatal Fc Receptor (FcRn) ELISA Kit

IMSFCRNKT each
EUR 890
Description: Mouse Neonatal Fc Receptor (FcRn) ELISA Kit

Mouse Neonatal Fc Receptor (FcRn) ELISA Kit

MBS8420553-1Kit 1Kit
EUR 755

Mouse Neonatal Fc Receptor (FcRn) ELISA Kit

MBS8420553-5x1Kit 5x1Kit
EUR 3455

Recombinant mouse FcRn Protein, Avi & His Tag

E40KMP1751 20ug
EUR 495

Recombinant mouse FcRn Protein, Avi His Tag

E40KMP2167 20ug
EUR 495

Recombinant Human FcRn protein, C-His Tag

MBS1560770-005mg 0.05mg
EUR 345

Recombinant Human FcRn protein, C-His Tag

MBS1560770-01mg 0.1mg
EUR 450

Recombinant Human FcRn protein, C-His Tag

MBS1560770-5x01mg 5x0.1mg
EUR 1710

Recombinant Human FcRn/FCGRT Protein, His Tag

E40KMH1078 20ug
EUR 495

Recombinant Mouse FcRn/Fcgrt Protein, His Tag

E40MOP2152 20ug
EUR 495

FcRn (FCGRT/B2M), His-Tag (Mouse) HiP™

11349 100 µg
EUR 320
Description: Mouse FcRn also known as Neonatal Fc receptor is a heterodimer of FCGRT (Fc Fragment of IgG Receptor and Transporter) and B2M (beta 2 microglobulin), GenBank Accession numbers NM_010189 and NM_009735; a.a. 22-297 and a.a. 1-119 respectively. FCGRT has a C-terminal His-Avi-tag. These proteins are co-expressed in a HEK293 expression system. FcRn MW = 34 kDa. B2M MW=14 kDa.

Recombinant Mouse FcRn & B2M Heterodimer (C-6His)

CK96-10ug 10ug
EUR 151.2
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Mouse FcRn & B2M Heterodimer (C-6His)

CK96-1mg 1mg
EUR 2252.4
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Mouse FcRn & B2M Heterodimer (C-6His)

CK96-500ug 500ug
EUR 1593.6
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Mouse FcRn & B2M Heterodimer (C-6His)

CK96-50ug 50ug
EUR 278.4
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Human FcRn & B2M Heterodimer (C-6His)

CI01-10ug 10ug
EUR 187.2
Description: Lyophilized from a 0.2 μm filtered solution of 50mM HEPES,150mM Nacl,pH7.4.

Recombinant Human FcRn & B2M Heterodimer (C-6His)

CI01-1mg 1mg
EUR 2739.6
Description: Lyophilized from a 0.2 μm filtered solution of 50mM HEPES,150mM Nacl,pH7.4.

Recombinant Human FcRn & B2M Heterodimer (C-6His)

CI01-500ug 500ug
EUR 1935.6
Description: Lyophilized from a 0.2 μm filtered solution of 50mM HEPES,150mM Nacl,pH7.4.

Recombinant Human FcRn & B2M Heterodimer (C-6His)

CI01-50ug 50ug
EUR 442.8
Description: Lyophilized from a 0.2 μm filtered solution of 50mM HEPES,150mM Nacl,pH7.4.

Recombinant Human FcRn & B2M Heterodimer (C-6His)

AP75984 1mg
EUR 3209

Recombinant Mouse FcRn & B2M Heterodimer (C-6His)

AP76211 1mg
EUR 2649

Recombinant Cynomolgus FcRn Protein, Avi His Tag

E40KMP1971 20ug
EUR 495

FCGRT / FcRn (IgG Transporter)(FCGRT/2932), 1mg/mL

BNUM2932-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FCGRT / FcRn (IgG Transporter)(FCGRT/2932), 0.2mg/mL

BNUB2932-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FCGRT / FcRn (IgG Transporter)(FCGRT/2932), 0.2mg/mL

BNUB2932-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FCGRT/FCRN Rabbit anti-Human Polyclonal Antibody

MBS2402875-005mL 0.05mL
EUR 615

FCGRT/FCRN Rabbit anti-Human Polyclonal Antibody

MBS2402875-5x005mL 5x0.05mL
EUR 2605

FCGRT/FCRN Rabbit anti-Human Polyclonal Antibody

MBS2403049-005mL 0.05mL
EUR 615

FCGRT/FCRN Rabbit anti-Human Polyclonal Antibody

MBS2403049-5x005mL 5x0.05mL
EUR 2605

Recombinant Mouse FcRn/FCGRT & B2M Heterodimer Protein

RP00694 50μg
EUR 41.8

Human IgG receptor FcRn large subunit p51 (FCGRT)

1-CSB-EP008545HU
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10ug
  • 50ug
  • 100ug
  • 200ug
  • 500ug
  • 1MG
Description: Recombinant Human IgG receptor FcRn large subunit p51(FCGRT),partial expressed in E.coli

Human IgG receptor FcRn large subunit p51 (FCGRT)

1-CSB-MP008545HU
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 200ug
  • 500ug
  • 1MG
Description: Recombinant Human IgG receptor FcRn large subunit p51(FCGRT),partial expressed in Mammalian cell

Human IgG receptor FcRn large subunit p51 (FCGRT)

1-CSB-YP008545HU
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10ug
  • 50ug
  • 100ug
  • 200ug
  • 500ug
  • 1MG
Description: Recombinant Human IgG receptor FcRn large subunit p51(FCGRT),partial expressed in Yeast

Cynomolgus / Rhesus Macaque FcRn (FCGRT & B2M), Fc Tag

E24PCA041 50 μg
EUR 200

Cynomolgus / Rhesus Macaque FcRn (FCGRT & B2M), His Tag

E24PCA042 50 μg
EUR 262

FCGRT, CT (FCGRT, FCRN, IgG receptor FcRn large subunit p51, IgG Fc fragment receptor transporter alpha chain, Neonatal Fc receptor)

MBS6001682-02mL 0.2(mL
EUR 695

FCGRT, CT (FCGRT, FCRN, IgG receptor FcRn large subunit p51, IgG Fc fragment receptor transporter alpha chain, Neonatal Fc receptor)

MBS6001682-5x02mL 5x0.2mL
EUR 2975

HEK293/FcRn (FCGRT & B2M), GFP Tag Stable Cell Line

CHEK-ATP132 2Vials
EUR 3858.6
Description: FCGRT & B2M heterodimer protein (FcRn complex) consist of two subunits: p51 (equivalent to FCGRT), and p14 (equivalent to beta-2-microglobulin), and forms an MHC class I-like heterodimer. Fc fragment of IgG, receptor, transporter, alpha (FCGRT) binds to the Fc region of monomeric immunoglobulins gamma and mediates the uptake of IgG from milk. FCGRT possible role in transfer of immunoglobulin G from mother to fetus. Beta-2-microglobulin (B2M) is a component of the class I major histocompatibility complex (MHC) and involved in the presentation of peptide antigens to the immune system.

FCGRT, CT (FCGRT, FCRN, IgG receptor FcRn large subunit p51, IgG Fc fragment receptor transporter alpha chain, Neonatal Fc receptor) (AP)

MBS6298670-02mL 0.2mL
EUR 980

FCGRT, CT (FCGRT, FCRN, IgG receptor FcRn large subunit p51, IgG Fc fragment receptor transporter alpha chain, Neonatal Fc receptor) (AP)

MBS6298670-5x02mL 5x0.2mL
EUR 4250

FCGRT, CT (FCGRT, FCRN, IgG receptor FcRn large subunit p51, IgG Fc fragment receptor transporter alpha chain, Neonatal Fc receptor) (APC)

MBS6298671-02mL 0.2mL
EUR 980

FCGRT, CT (FCGRT, FCRN, IgG receptor FcRn large subunit p51, IgG Fc fragment receptor transporter alpha chain, Neonatal Fc receptor) (APC)

MBS6298671-5x02mL 5x0.2mL
EUR 4250

FCGRT, CT (FCGRT, FCRN, IgG receptor FcRn large subunit p51, IgG Fc fragment receptor transporter alpha chain, Neonatal Fc receptor) (PE)

MBS6298680-02mL 0.2mL
EUR 980

FCGRT, CT (FCGRT, FCRN, IgG receptor FcRn large subunit p51, IgG Fc fragment receptor transporter alpha chain, Neonatal Fc receptor) (PE)

MBS6298680-5x02mL 5x0.2mL
EUR 4250

Recombinant Human IgG receptor FcRn large subunit p51

MBS9422292-002mg 0.02mg
EUR 320

Recombinant Human IgG receptor FcRn large subunit p51

MBS9422292-01mg 0.1mg
EUR 540

Recombinant Human IgG receptor FcRn large subunit p51

MBS9422292-1mg 1mg
EUR 2070

Recombinant Human IgG receptor FcRn large subunit p51

MBS9422292-5x1mg 5x1mg
EUR 9160

Recombinant Human IgG receptor FcRn large subunit p51

MBS9420235-002mg 0.02mg
EUR 285

Recombinant Human IgG receptor FcRn large subunit p51

MBS9420235-01mg 0.1mg
EUR 470

Recombinant Human IgG receptor FcRn large subunit p51

MBS9420235-1mg 1mg
EUR 1785

Recombinant Human IgG receptor FcRn large subunit p51

MBS9420235-5x1mg 5x1mg
EUR 7885

Recombinant Human FcRn & B2M Heterodimer Protein (His Tag)

PKSH032422-10ug 10ug
EUR 129
Description: Human

Recombinant Human FcRn & B2M Heterodimer Protein (His Tag)

PKSH032422-50ug 50ug
EUR 375
Description: Human

Recombinant Mouse FcRn & B2M Heterodimer Protein (His Tag)

PKSM041017-10ug 10ug
EUR 92
Description: Mouse

Recombinant Mouse FcRn & B2M Heterodimer Protein (His Tag)

PKSM041017-50ug 50ug
EUR 214
Description: Mouse

IgG receptor FcRn large subunit p51 Polyclonal Antibody

42167 100μg
EUR 390

IgG receptor FcRn large subunit p51 Polyclonal Antibody

42167-100ul 100ul
EUR 399.6

Fc (IgG1): FcRn Inhibitor Screening Colorimetric Assay Kit

78501 96 rxns.
EUR 830
Description: The Fc (IgG1): FcRn Inhibitor Screening Colorimetric Assay Kit is designed for screening and profiling neutralizing antibodies or inhibitors of the interaction between Fc (IgG1) and human FcRn. _x000D_The assay requires only a few steps. First, Fc (IgG1) is coated on a 96-well plate overnight. After blocking, the protein is pre-incubated with the inhibitor or neutralizing antibody. Upon subsequent incubation with Biotin-FcRn, the plate is treated with Streptavidin-HRP followed by addition of a colorimetric HRP substrate to produce color, which can be quenched and measured using a UV/Vis microplate reader.

Recombinant Human FcRn & B2M Heterodimer Protein (C-6His)

MBS2552658-001mg 0.01mg
EUR 180

Recombinant Human FcRn & B2M Heterodimer Protein (C-6His)

MBS2552658-005mg 0.05mg
EUR 380

Recombinant Human FcRn & B2M Heterodimer Protein (C-6His)

MBS2552658-5x005mg 5x0.05mg
EUR 1690

Recombinant Mouse FcRn & B2M Heterodimer Protein (C-6His)

MBS2553494-001mg 0.01mg
EUR 155

Recombinant Mouse FcRn & B2M Heterodimer Protein (C-6His)

MBS2553494-005mg 0.05mg
EUR 240

Recombinant Mouse FcRn & B2M Heterodimer Protein (C-6His)

MBS2553494-5x005mg 5x0.05mg
EUR 1080

IgG receptor FcRn large subunit p51 Polyclonal Antibody

MBS9415363-01mg 0.1mg
EUR 350

IgG receptor FcRn large subunit p51 Polyclonal Antibody

MBS9415363-5x01mg 5x0.1mg
EUR 1420

FCGRT, CT (FCGRT, FCRN, IgG receptor FcRn large subunit p51, IgG Fc fragment receptor transporter alpha chain, Neonatal Fc receptor) (Biotin)

MBS6298672-02mL 0.2mL
EUR 980

FCGRT, CT (FCGRT, FCRN, IgG receptor FcRn large subunit p51, IgG Fc fragment receptor transporter alpha chain, Neonatal Fc receptor) (Biotin)

MBS6298672-5x02mL 5x0.2mL
EUR 4250

FCGRT, CT (FCGRT, FCRN, IgG receptor FcRn large subunit p51, IgG Fc fragment receptor transporter alpha chain, Neonatal Fc receptor) (FITC)

MBS6298673-02mL 0.2mL
EUR 980

FCGRT, CT (FCGRT, FCRN, IgG receptor FcRn large subunit p51, IgG Fc fragment receptor transporter alpha chain, Neonatal Fc receptor) (FITC)

MBS6298673-5x02mL 5x0.2mL
EUR 4250

Rat IgG receptor FcRn large subunit p51 ELISA Kit

MBS2884822-10x96StripWells 10x96-Strip-Wells
EUR 4630

Rat IgG receptor FcRn large subunit p51 ELISA Kit

MBS2884822-48StripWells 48-Strip-Wells
EUR 440

Rat IgG receptor FcRn large subunit p51 ELISA Kit

MBS2884822-5x96StripWells 5x96-Strip-Wells
EUR 2480

Rat IgG receptor FcRn large subunit p51 ELISA Kit

MBS2884822-96StripWells 96-Strip-Wells
EUR 580

Mouse IgG receptor FcRn large subunit p51 ELISA Kit

EK3291 96 tests
EUR 739

Human IgG receptor FcRn large subunit p51 ELISA Kit

EK3292 96 tests
EUR 636

Human IgG receptor FcRn large subunit p51 ELISA Kit

MBS2884293-10x96StripWells 10x96-Strip-Wells
EUR 4080

Human IgG receptor FcRn large subunit p51 ELISA Kit

MBS2884293-48StripWells 48-Strip-Wells
EUR 390

Human IgG receptor FcRn large subunit p51 ELISA Kit

MBS2884293-5x96StripWells 5x96-Strip-Wells
EUR 2220

Human IgG receptor FcRn large subunit p51 ELISA Kit

MBS2884293-96StripWells 96-Strip-Wells
EUR 520

The “Four-Anti and Two-Balance” strategy effectively increased cure rate and reduced mortality. Early antiviral treatment could alleviate disease severity and prevent illness progression, and we found lopinavir/ritonavir combined with abidol showed antiviral effects in COVID-19. Shock and hypoxemia were usually caused by cytokine storms. The artificial liver blood purification system could rapidly remove inflammatory mediators and block cytokine storm.Moreover, it also favored the balance of fluid, electrolyte and acid-base and thus improved treatment efficacy in critical illness. For cases of severe illness, early and also short period of moderate glucocorticoid was supported. Patients with oxygenation index below 200 mmHg should be transferred to intensive medical center.

Conservative oxygen therapy was preferred and noninvasive ventilation was not recommended. Patients with mechanical ventilation should be strictly supervised with cluster ventilator-associated pneumonia prevention strategies. Antimicrobial prophylaxis was not recommended except for patients with long course of disease, repeated fever and elevated procalcitonin (PCT), meanwhile secondary fungal infection should be concerned.Some patients with COVID-19 showed intestinal microbial dysbiosis with decreased probiotics such as Lactobacillus and Bifidobacterium, so nutritional and gastrointestinal function should be assessed for all patients.Nutritional support and application of prebiotics or probiotics were suggested to regulate the balance of intestinal microbiota and reduce the risk of secondary infection due to bacterial translocation. Anxiety and fear were common in patients with COVID-19.

Therefore,we established dynamic assessment and warning for psychological crisis. We also integrated Chinese medicine in treatment to promote disease rehabilitation through classification methods of traditional Chinese medicine. We optimized nursing process for severe patients to promote their rehabilitation. It remained unclear about viral clearance pattern after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Therefore, two weeks’ quarantine for discharged patients was required and a regular following up was also needed.The Zhejiang experience and suggestions have been implemented in our center and achieved good results. However, since COVID-19 was a newly emerging disease, more work was warranted to improve strategies of prevention, diagnosis and treatment for COVID-19.